Skip to main content
. 2022 Jul 15;14(7):5088–5097.

Table 1.

Information of the variants identified in this study

Patient No. Variant No. Gene (transcript) Genomic alteration Protein alteration Frequencies in 3 databases* Revel score* HGMD* level (PMID*) ACMG* level (evidence)
1 1 CC2D2A (NM_001080522) c.2444delC p.P815fs*2 0; 0; 0 / / Likely pathogenic (PVS1+PM2)
2 c.4238G>A p.C1413Y 0.002; 0.004406; 0.004347 0.306 DM (27491411) Likely pathogenic (PM3_Strong+PM3+BP4)
2 3 NPHP1 del exon (1-20) null / / DM (multi studies) Likely pathogenic (PVS1+PM2)
3 4 AHI1 (NM_017651) c.910dupA p.T304Nfs*5 0; 0; 0 / DM (16453322) Pathogenic (PVS+PS1+PM2)
5 del exon (15-17) uncertain / / / Pathogenic (PVS1+PM2+PM3)
4 6 C5orf42 (NM_023073) c.4006C>T p.R1336W 0; 0; 0 0.273 DM (22425360) Likely pathogenic (PM2+PM3)
7 c.3551G>A p.R1184H 0; 0; 0 0.797 DM (25407461) Likely pathogenic (PM2+PM3+PM5+PP3)
*

1000g2015aug_eas (https://www.internationalgenome.org/); ExAC_EAS (http://exac.broadinstitute.org); gnomAD_exome_EAS (http://gnomad.broadinstitute.org/); Revel: An ensemble method for predicting the pathogenicity of missense variants on the basis of individual tools: MutPred, FATHMM, VEST, PolyPhen, SIFT, PROVEAN, MutationAssessor, MutationTaster, LRT, GERP, SiPhy, phyloP, and phastCons (http://dx.doi.org/10.1016/j.ajhg.2016.08.016); HGMD®: Human Gene Mutation Database (Professional Version 2019.4); PMID: PubMed ID (https://pubmed.ncbi.nlm.nih.gov/); ACMG: The American College of Medical Genetics and Genomics; P: pathogenic; LP: likely pathogenic; VUS: variants of unknown significance.